Company | CF Industries Holdings, Inc. |
Ticker | NYSE: CF |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Earnings Release | After market close, Wednesday August 5, 2026 |
Conference Call | Thursday August 6, 2026 at 11:00 a.m. ET |
Document Prepared | August 4, 2026 |
Last Earnings Date | May 6, 2026 (Q1 2026) |
Key Takeaway: The setup is constructive but nuanced — consensus has been revised sharply higher since Q1 (Q2 EPS consensus ~$5.59 vs. ~$2.75 at last earnings), yet the stock already priced in much of the geopolitical tailwind; the biggest swing factor is whether realized urea and ammonia prices in Q2 tracked the elevated global benchmarks or were dampened by North America's status as the world's lowest-priced market during the quarter.
Heading into CF's Q2 2026 print, the bar is meaningfully higher than it was a quarter ago, with consensus Adjusted EBITDA at ~$1.35B and operating EPS at ~$5.59 — both reflecting the dramatic upward revision cycle triggered by the Iran conflict and Strait of Hormuz supply shock that began late in Q1. Management's tone at the May 13 BMO conference was structurally bullish: Bert Frost described a "unique supply-limited market," flagged India's urea import requirements rising to 10–13 million metric tons (above the 10–12 million cited at Q1 earnings), and confirmed the fill program would launch in early August with channel inventories expected to be near-empty by end of June — a clean setup for strong fill-season pricing. Estimate revisions have tracked guidance directionally, with Q2 EPS moving from $2.75 at the Q1 print to $5.59 currently, though the FY2026 consensus of $16.47 implies a meaningful step-down in H2 that may prove conservative if the geopolitical premium persists. The stock declined sharply on Q1 earnings day despite a large beat (suggesting the Iran tailwind was priced in), then traded in a wide range of ~$102–$130 before recovering to ~$118 ahead of this print — the multiple has compressed from ~12.7x NTM P/E six months ago to ~8.95x today, leaving room for re-rating if Q2 results and Q3 fill-program commentary exceed expectations. The key wildcard is the timing and pricing of the summer fill program: management guided for an early-August launch with near-zero channel inventory, and any color on fill-program volumes, pricing, or customer demand will likely drive the stock more than the Q2 reported numbers themselves.
Key Takeaway: Consensus is a high bar in absolute terms but may be achievable given the geopolitical supply shock that persisted through Q2; urea and ammonia realized pricing are the bigger swing factors — consensus urea ASP of ~$592/ton and ammonia ASP of ~$663/ton imply significant YoY improvement, and any miss on volumes (given the Yazoo City outage and North America's role as the world's lowest-priced market in Q2) could offset pricing upside.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Guidance / Mgmt Commentary |
Net Sales ($M) | $1,986M | $1,890M | $2,429M | +28.5% | No specific Q2 guidance; tight global supply expected to support pricing |
Adjusted EBITDA ($M) | $983M | $761M | $1,348M | +77.1% | No specific Q2 guidance; FY2026 CapEx ~$1.3B consolidated |
EPS — Diluted Operating ($) | $3.98 | $2.37 | $5.59 | +136% | No specific Q2 EPS guidance provided |
Avg. Selling Price — Urea ($/ton) | $457/ton | $460/ton | $592/ton | +28.7% | NOLA ~$600/short ton at Q1 call; offshore $700–$800/MT; North America lowest-priced market globally |
Avg. Selling Price — Ammonia ($/ton) | $568/ton | $452/ton | $663/ton | +46.7% | Geopolitical risk premium expected to persist; pricing "higher than normal for longer" |
Sales Volume — Urea (Kshort tons) | 1,291 Ktons | 1,188 Ktons | 1,247 Ktons | +4.9% | Donaldsonville turnaround shifted to late June; product mix favoring urea over UAN |
Sales Volume — Ammonia (Kshort tons) | 1,103 Ktons | 1,087 Ktons | 1,033 Ktons | -5.0% | Yazoo City outage (offline until late Q4 2026 at earliest) constrains AN/DEF; ammonia volumes broadly stable |
Natural Gas Cost ($/MMBtu) | $4.57/MMBtu | ~$3.68/MMBtu (Q1 2025 proxy) | N/A — not in VA | N/A | Mgmt expects remainder of year to track NYMEX strip (~$2.60 at Q1 call); not hedged |
Source: Visible Alpha Consensus and Actuals Data
Quarter | Reported ($M) | Consensus ($M) | Surprise % | Result |
Q1 2026 | $983 | $784 | +25.4% | BEAT |
Q4 2025 | $821 | $750 | +9.5% | BEAT |
Q3 2025 | $667 | $680 | -1.9% | MISS |
Q2 2025 | $761 | $776 | -1.9% | MISS |
Q1 2025 | $644 | $538 | +19.7% | BEAT |
Q4 2024 | $562 | $586 | -4.1% | MISS |
Q3 2024 | $511 | $501 | +2.0% | BEAT |
Q2 2024 | N/A — pre-range | N/A | N/A | N/A |
Quarter | Reported ($) | Consensus ($) | Surprise % | Result |
Q1 2026 | $3.98 | $2.75 | +44.7% | BEAT |
Q4 2025 | $2.59 | $2.52 | +2.8% | BEAT |
Q3 2025 | $2.19 | $2.19 | 0.0% | IN-LINE |
Q2 2025 | $2.37 | $2.47 | -4.0% | MISS |
Q1 2025 | $1.85 | $1.38 | +34.1% | BEAT |
Q4 2024 | $1.89 | $1.52 | +24.3% | BEAT |
Q3 2024 | $1.55 | $1.17 | +32.5% | BEAT |
Q2 2024 | N/A — pre-range | N/A | N/A | N/A |
Pattern: CF has beaten on operating EPS in 6 of the last 7 reported quarters, with the one miss (Q2 2025) occurring in a softer pricing environment; the Q1 2026 beat of +44.7% was the largest in the series, driven by the Iran supply shock and a one-time litigation settlement gain. The EBITDA beat/miss pattern is more mixed, with two consecutive misses in Q2–Q3 2025 before the sharp Q1 2026 beat, suggesting the bar on EBITDA is harder to clear when pricing is volatile.
Source: Visible Alpha Consensus and Actuals Data
Key Takeaway: Management has not issued formal numerical Q2 guidance, but tone has escalated from bullish to structurally bullish since the Q1 print — the BMO conference on May 13 raised India import estimates, confirmed near-empty channel inventory, and locked in an early-August fill program launch, all of which are incremental positives versus the Q1 call.
Metric | Initial Guidance (Q1 2026 Earnings Call, May 6–7) | Revised Guidance / Post-Earnings Update | Current Consensus | Note |
FY2026 CapEx (consolidated) | ~$1.3B total; CF portion ~$950M (incl. $550M sustaining + ~$400M Blue Point JV & common infra) | Unchanged | N/A — not in VA | Confirmed at BMO conference May 13; no change |
FY2026 Gross Ammonia Production | ~9.5M tons (impacted by Yazoo City outage; not expected to resume until late Q4 2026 at earliest) | Unchanged | N/A — not in VA | Yazoo City outage ongoing; no update to production guidance |
India Urea Import Estimate | 10–12 million metric tons (Q1 earnings call) | ↑ Raised to 10–13 million metric tons at BMO conference May 13 | N/A | ↑ Raised at BMO Farm to Market Conference May 13, 2026; reflects continued deterioration in Indian domestic production due to LNG shortages |
Nitrogen Pricing Outlook | "Higher than normal for longer"; NOLA ~$600/short ton; offshore $700–$800/MT; North America lowest-priced market globally | Unchanged in direction; prices "quite a bit up in the last week" per Yara Q2 call (July 17) | Urea ASP consensus $592/ton; Ammonia ASP $663/ton | Consistent with bullish tone; no formal revision |
Summer Fill Program | Expected to be a Q3 event; launch communicated ~1 month in advance | ↑ Confirmed early August launch at BMO conference; channel expected near-empty by end of June | N/A | ↑ More specific timing provided at BMO May 13; "sometime in early August" — incrementally positive |
Share Repurchase | $1.7B remaining on $2B authorization (expires Dec 2029); Q1 pace light (~$15M) due to Iran conflict uncertainty; intention to execute in full | ↑ Dividend raised 20% to $0.60/share (announced July 8, 2026; payable Aug 31 to holders of record Aug 14) | N/A | ↑ Dividend increase announced via press release July 8, 2026; signals management confidence in cash generation; buyback pace expected to accelerate |
Blue Point Project | Civil construction to commence 2026 pending permits; operational late 2029; adds >1.5M tons gross ammonia capacity | Unchanged; inflation risk on modules dismissed at BMO | N/A | Module sourcing locked in; current activity on groundwork, pilings, bridge infrastructure; no cost escalation risk flagged |
Key Takeaway: Estimates have been revised sharply higher since the Q1 print — Q2 2026 operating EPS moved from $2.75 to $5.59 (+103%) and FY2026 EPS from $17.00 to $16.47 (a modest -3.1% decline, reflecting the Q1 beat being partially offset by a more conservative H2 view); the gap between the elevated Q2 bar and the conservative FY2026 H2 implied run-rate represents the key risk/opportunity heading into the print.
KPI (Period) | Estimate at Q1 Earnings +5 Days (May 13, 2026) | Current Consensus (Aug 4, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance |
EPS — Diluted Operating (Q2 2026) | $5.68 | $5.59 | -1.6% | No formal guidance | No formal guidance | N/A | N/A |
Net Sales (Q2 2026) | $2,430M | $2,429M | -0.04% | No formal guidance | No formal guidance | N/A | N/A |
Adj. EBITDA (Q2 2026) | $1,391M | $1,348M | -3.1% | No formal guidance | No formal guidance | N/A | N/A |
Urea ASP (Q2 2026) | $607/ton | $592/ton | -2.5% | NOLA ~$600/short ton (Q1 call) | Unchanged | N/A | Consensus slightly below mgmt commentary |
Ammonia ASP (Q2 2026) | $644/ton | $663/ton | +2.9% | "Higher than normal for longer" | Unchanged | N/A | Consensus tracking mgmt tone |
EPS — Diluted Operating (FY2026) | $17.00 | $16.47 | -3.1% | No formal FY guidance | No formal FY guidance | N/A | N/A |
Net Sales (FY2026) | $8,388M | $8,551M | +1.9% | No formal FY guidance | No formal FY guidance | N/A | N/A |
Adj. EBITDA (FY2026) | $4,384M | $4,239M | -3.3% | No formal FY guidance | No formal FY guidance | N/A | N/A |
The Q2 2026 estimate has been remarkably stable since the Q1 print (+5 days baseline), with EBITDA and EPS both drifting only slightly lower (-3%) — suggesting the street has high conviction in the Q2 number. The more interesting dynamic is the FY2026 EBITDA consensus of $4.24B, which implies H2 2026 EBITDA of only ~$2.89B vs. H1's ~$2.33B — a meaningful step-up that depends on the fill program executing at elevated prices. If management provides strong fill-program color on the Q2 call, FY2026 estimates could move higher.
Source: Visible Alpha Consensus and Actuals Data
Key Takeaway: CF's post-Q1 stock performance has been driven primarily by multiple compression rather than earnings growth — the NTM EV/EBITDA multiple has contracted from ~7.6x six months ago to ~6.4x today even as estimates surged, suggesting the market is discounting the sustainability of the geopolitical premium; the stock is up ~+1.2% vs. the Q1 earnings date close but has significantly underperformed the S&P 500 (+5.1%) and broadly tracked XLB.
Chart: CF vs. XLB (Materials Select Sector SPDR ETF) vs. S&P 500 (SPY) — Indexed to 100 at May 6, 2026 (Q1 2026 Earnings Date)
Date | CF (Indexed) | XLB (Indexed) | SPY (Indexed) |
May 6, 2026 (Q1 Earnings) | 100.0 | 100.0 | 100.0 |
May 13, 2026 (BMO Conference) | 104.8 | 99.3 | 101.1 |
May 29, 2026 (Month-end) | 93.8 | 97.6 | 103.1 |
Jun 8, 2026 (Trough) | 91.4 | 95.3 | 100.7 |
Jun 30, 2026 (Quarter-end) | 90.4 | 97.0 | 101.8 |
Jul 8, 2026 (Dividend +20% Announced) | 97.7 | 95.7 | 101.6 |
Jul 22, 2026 (Recent Peak) | 106.3 | 97.0 | 101.8 |
Aug 3, 2026 (Pre-Earnings) | 98.8 | 97.3 | 103.2 |
Note: Indexed to 100 at May 6, 2026 close (CF: $119.76, XLB: $52.41, SPY: $733.83). XLB (Materials Select Sector SPDR ETF) is the appropriate sector benchmark for CF as a large-cap materials/chemicals producer. CF has underperformed both XLB and SPY since the Q1 earnings date, with the stock declining from its post-earnings peak of ~$130 (May 12) to ~$118 ahead of the Q2 print. The NTM EV/EBITDA multiple has compressed from ~7.6x (6 months ago) to ~6.4x currently, suggesting the market is pricing in mean-reversion in nitrogen prices rather than a sustained geopolitical premium.
Source: Stock Price Data (Yahoo Finance)
Key Takeaway: The most important post-Q1 development is the 20% dividend increase announced July 8, which signals management's high confidence in sustained free cash flow generation and is a direct positive for the Q2 print; the ongoing Iran conflict and Strait of Hormuz supply disruption remain the dominant macro driver for nitrogen pricing.
Key Takeaway: Peer commentary from the current reporting window is broadly constructive for CF's Q2 print: Yara's Q2 call (July 17) confirmed elevated nitrogen pricing driven by the Middle East supply shock, with prices "quite a bit up in the last week" and demand picking up into Q3; LyondellBasell's Q2 beat (July 31) cited geopolitical supply chain tailwinds from the Iran war; and Mosaic's Q2 data (August 4) shows ammonia input costs of $621–$815/ton, confirming the elevated nitrogen price environment. The key nuance from Yara is that demand was softer than expected in Q2 due to buyer hesitation at peak prices, which could weigh on CF's Q2 volumes even as pricing was strong.
Methodology Note: Only commentary dated June 5–August 4, 2026 that addresses the current Q2/June-quarter market or subsequent current-quarter outlook is included below. Prior-quarter results commentary (e.g., Q1 2026 results discussed on Q1 earnings calls) is excluded. Direct nitrogen read-throughs are clearly distinguished from indirect phosphate/potash context.
Relevance: Yara is the world's largest nitrogen fertilizer producer and the most direct read-through for CF's nitrogen pricing, demand, and volume dynamics.
Relevance: Mosaic is a major phosphate and potash producer; its ammonia input costs provide a direct market data point for nitrogen pricing in Q2 2026.
Key Takeaway: No open-market insider purchases or discretionary sales were identified for CF Industries in the post-Q1 window (May 6 – August 4, 2026); the absence of insider buying at current prices (~$118–$130 range) is notable given management's vocal view that the stock is trading below intrinsic value, though the CFO transition (Andrew Scribner appointed May 5) may have created a blackout period.
Name | Title | Transaction Type | Value | Date | Note |
N/A | N/A | N/A | N/A | N/A | No open-market insider transactions (Form 4 codes P/S) identified for CF in the May 6 – August 4, 2026 window per SEC Form 4 database query |
Context: The lack of insider buying is a mild negative signal given management's repeated assertion that the stock is "shockingly undervalued" and trades below intrinsic value. However, the CFO transition (Andrew Scribner appointed May 5, 2026) likely imposed a blackout period, and the pre-earnings quiet period (typically 30 days before the August 5 release) would have further restricted trading. The company's aggressive share repurchase program ($1.7B remaining) serves as the primary vehicle for capital return, and the 20% dividend increase on July 8 is a strong signal of management confidence in cash generation.